NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 16 04:00PM ET
6.68
Dollar change
-0.05
Percentage change
-0.74
%
IndexRUT P/E- EPS (ttm)-2.34 Insider Own3.69% Shs Outstand50.14M Perf Week-5.52%
Market Cap334.91M Forward P/E- EPS next Y-0.76 Insider Trans-12.10% Shs Float48.29M Perf Month19.07%
Income-115.84M PEG- EPS next Q-0.27 Inst Own92.60% Short Float5.48% Perf Quarter-0.74%
Sales214.83M P/S1.56 EPS this Y59.36% Inst Trans6.15% Short Ratio4.97 Perf Half Y-15.97%
Book/sh7.23 P/B0.92 EPS next Y24.77% ROA-12.77% Short Interest2.65M Perf Year-50.30%
Cash/sh4.87 P/C1.37 EPS next 5Y34.38% ROE-24.08% 52W Range4.58 - 14.20 Perf YTD-14.14%
Dividend Est.- P/FCF- EPS past 5Y-35.29% ROI-18.59% 52W High-52.96% Beta1.90
Dividend TTM- Quick Ratio5.24 Sales past 5Y63.51% Gross Margin37.54% 52W Low45.85% ATR (14)0.56
Dividend Ex-Date- Current Ratio5.56 EPS Y/Y TTM5.24% Oper. Margin-27.86% RSI (14)57.92 Volatility8.58% 8.09%
Employees1186 Debt/Eq0.61 Sales Y/Y TTM-4.53% Profit Margin-53.92% Recom1.89 Target Price10.44
Option/ShortYes / Yes LT Debt/Eq0.56 EPS Q/Q34.33% Payout- Rel Volume0.89 Prev Close6.73
Sales Surprise2.07% EPS Surprise18.84% Sales Q/Q-24.82% EarningsMay 07 AMC Avg Volume532.55K Price6.68
SMA209.88% SMA5011.69% SMA200-7.70% Trades Volume475,735 Change-0.74%
Date Action Analyst Rating Change Price Target Change
Mar-24-25Upgrade UBS Neutral → Buy $10
Dec-19-24Initiated Guggenheim Buy $11
Aug-07-24Downgrade Jefferies Buy → Hold $20 → $8
Jul-31-24Upgrade B. Riley Securities Neutral → Buy $19 → $15
May-03-24Downgrade B. Riley Securities Buy → Neutral $22 → $19
Apr-04-24Resumed Jefferies Buy $17 → $21
Mar-13-24Reiterated Needham Buy $19 → $18
Aug-17-23Initiated Morgan Stanley Equal-Weight $16
Aug-10-23Downgrade Stephens Overweight → Equal-Weight $15
Jul-18-23Downgrade UBS Buy → Neutral $28 → $17
May-12-25 09:55AM
May-08-25 03:34AM
May-07-25 07:15PM
07:15PM
05:20PM
04:05PM Loading…
04:05PM
May-06-25 09:35AM
Apr-30-25 10:01AM
Apr-24-25 08:30AM
Apr-10-25 10:39AM
Apr-04-25 06:03AM
Mar-31-25 03:11PM
09:06AM
08:09AM
Mar-26-25 09:15AM
07:59PM Loading…
Mar-18-25 07:59PM
Mar-13-25 07:28AM
Mar-12-25 08:30AM
Mar-05-25 02:10AM
Mar-04-25 05:35PM
04:10PM
Mar-03-25 07:18AM
Feb-18-25 08:30AM
Jan-21-25 08:30AM
Jan-14-25 08:30AM
Jan-06-25 08:30AM
Nov-12-24 08:30AM
Nov-08-24 04:03PM
Nov-07-24 05:55PM
04:05PM
07:37AM Loading…
Nov-06-24 07:37AM
Oct-31-24 10:01AM
Oct-29-24 08:30AM
Oct-22-24 08:30AM
Oct-21-24 08:30AM
Oct-15-24 08:30AM
Oct-07-24 08:30AM
Sep-25-24 08:30AM
Sep-09-24 05:28AM
Aug-19-24 03:27AM
Aug-06-24 07:00PM
04:15PM
04:05PM
Jul-23-24 08:30AM
Jul-12-24 02:46AM
Jul-09-24 09:35AM
Jun-20-24 08:30AM
May-17-24 02:33AM
May-08-24 02:54PM
04:03AM
May-07-24 09:56PM
06:18PM
04:08PM
May-03-24 10:12AM
06:41AM
Apr-30-24 08:30AM
Apr-25-24 10:02AM
Mar-13-24 09:16AM
Mar-12-24 05:52PM
05:30PM
04:05PM
Feb-27-24 08:30AM
Feb-15-24 10:00AM
Feb-13-24 09:55AM
Nov-27-23 08:30AM
Nov-21-23 03:26PM
Nov-16-23 08:30AM
Nov-09-23 05:23PM
Nov-08-23 06:05PM
04:05PM
Nov-02-23 08:30AM
Oct-26-23 10:02AM
Oct-25-23 08:30AM
Oct-12-23 08:30AM
Oct-10-23 08:30AM
Oct-09-23 04:05PM
Sep-14-23 08:30AM
Aug-10-23 07:14AM
Aug-09-23 05:30PM
04:05PM
Aug-02-23 08:30AM
Jul-31-23 08:53AM
Jul-23-23 08:17AM
Jul-13-23 12:24PM
11:17AM
Jul-12-23 04:05PM
12:56PM
Jun-29-23 08:39AM
May-25-23 08:02AM
May-12-23 07:15AM
May-04-23 06:05PM
04:05PM
Apr-27-23 10:02AM
08:30AM
Apr-25-23 08:30AM
Apr-01-23 08:54AM
Mar-28-23 08:30AM
Mar-16-23 03:46AM
Mar-13-23 06:00AM
Mar-08-23 01:15PM
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sawicki Mark WChief Scientific OfficerMar 24 '25Sale6.941,3499,36484,087Mar 26 07:01 PM
STEFANOVICH ROBERTChief Financial OfficerMar 24 '25Sale6.941,0707,428190,349Mar 26 07:00 PM
SHELTON JERRELLPresident, CEOMar 24 '25Sale6.942,98020,686762,419Mar 26 07:00 PM
ZECCHINI EDWARD JChief Digital and Tech OfficerMar 17 '25Sale6.291,1407,17366,911Mar 18 07:08 PM
STEFANOVICH ROBERTChief Financial OfficerMar 17 '25Sale6.291,65910,438191,419Mar 18 07:07 PM
Sawicki Mark WChief Scientific OfficerMar 17 '25Sale6.292,09213,16285,436Mar 18 07:06 PM
SHELTON JERRELLPresident, CEOMar 17 '25Sale6.294,62029,068765,399Mar 18 07:05 PM
Sawicki Mark WChief Scientific OfficerMar 09 '25Option Exercise0.002,667080,111Mar 11 07:01 PM
Sawicki Mark WChief Scientific OfficerMar 10 '25Sale4.881,5837,72478,528Mar 11 07:01 PM
SHELTON JERRELLPresident, CEOMar 09 '25Option Exercise0.008,2500744,192Mar 11 07:01 PM
SHELTON JERRELLPresident, CEOMar 10 '25Sale4.884,17320,360740,019Mar 11 07:01 PM
STEFANOVICH ROBERTChief Financial OfficerMar 09 '25Option Exercise0.002,6670184,334Mar 11 07:00 PM
STEFANOVICH ROBERTChief Financial OfficerMar 10 '25Sale4.881,2566,128183,078Mar 11 07:00 PM
STEFANOVICH ROBERTChief Financial OfficerDec 11 '24Option Exercise4.8053,334256,003181,667Dec 13 06:13 PM
Mandalam RamkumarDirectorDec 02 '24Option Exercise4.8010,83452,00366,866Dec 04 07:00 PM
Mandalam RamkumarDirectorDec 02 '24Sale7.467,36954,97859,497Dec 04 07:00 PM
Hariri Robert JDirectorNov 21 '24Sale6.482,50016,20020,561Dec 02 07:00 PM
RAMKUMAR MANDALAMDirectorDec 02 '24Proposed Sale7.087,36952,173Dec 02 04:43 PM
SHELTON JERRELLPresident, CEONov 21 '24Option Exercise4.8059,150283,920781,897Nov 25 07:00 PM
SHELTON JERRELLPresident, CEONov 22 '24Option Exercise4.8026,862128,938758,759Nov 25 07:00 PM
SHELTON JERRELLPresident, CEONov 21 '24Sale6.5150,000325,275731,897Nov 25 07:00 PM
SHELTON JERRELLPresident, CEONov 22 '24Sale6.4722,817147,612735,942Nov 25 07:00 PM
JERRELL W SHELTONDirectorNov 22 '24Proposed Sale6.5222,817148,767Nov 22 04:31 PM
SHELTON JERRELLPresident, CEONov 19 '24Option Exercise4.8060,440290,112762,747Nov 20 07:57 PM
SHELTON JERRELLPresident, CEONov 18 '24Option Exercise4.8060,215289,032752,307Nov 20 07:57 PM
SHELTON JERRELLPresident, CEONov 20 '24Option Exercise4.8060,000288,000772,747Nov 20 07:57 PM
SHELTON JERRELLPresident, CEONov 19 '24Sale6.7850,000338,985712,747Nov 20 07:57 PM
SHELTON JERRELLPresident, CEONov 18 '24Sale6.7350,000336,540702,307Nov 20 07:57 PM
SHELTON JERRELLPresident, CEONov 20 '24Sale6.6550,000332,295722,747Nov 20 07:57 PM
JERRELL W SHELTONDirectorNov 20 '24Proposed Sale6.93100,000693,500Nov 20 04:33 PM
JERRELL W SHELTONDirectorNov 19 '24Proposed Sale6.7050,000335,000Nov 19 04:30 PM
JERRELL W SHELTONDirectorNov 18 '24Proposed Sale6.9950,000349,500Nov 18 05:14 PM
Hariri Robert JDirectorAug 19 '24Sale9.461,0009,46523,061Aug 26 07:11 PM
Hariri Robert JDirectorAug 16 '24Sale9.001,0009,00023,561Aug 20 05:28 PM
Hariri Robert JDirectorAug 14 '24Sale8.401,0008,39524,561Aug 20 05:28 PM
Mandalam RamkumarDirectorAug 02 '24Option Exercise5.044,16721,00260,199Aug 06 08:00 PM
Mandalam RamkumarDirectorAug 02 '24Sale8.044,16733,52056,032Aug 06 08:00 PM
RAMKUMAR MANDALAMDirectorAug 02 '24Proposed Sale8.704,16736,253Aug 02 04:22 PM